T cells
Filippos Porichis: Immunoregulator
Filippos Porichis: Immunoregulator
Kerry Grens | May 1, 2015
Principal Investigator, Ragon Institute of MGH, MIT, and Harvard. Age: 33
Opinion: Predicting the Efficacy of Cancer Immunotherapy
Opinion: Predicting the Efficacy of Cancer Immunotherapy
Jacob Richards | Apr 22, 2015
T-cell receptor repertoires could help researchers determine whether a certain treatment will work for a given cancer patient. 
Protein Spurs T-Cell Proliferation
Protein Spurs T-Cell Proliferation
Jef Akst | Apr 17, 2015
A newly discovered protein promotes immunity to viruses and cancer by triggering the production of cytotoxic T cells.
Studying Ebola Survivors
Studying Ebola Survivors
Amanda B. Keener | Apr 6, 2015
A scientist jumps at the chance to study the blood of four Ebola survivors to better understand how the immune system responds to the deadly virus. 
Another CAR-T IPO
Another CAR-T IPO
Jef Akst | Apr 6, 2015
Cellectis goes public for a whopping $228 million—nearly double the value the company filed for in February.
Cancer Immunotherapist
Cancer Immunotherapist
Jef Akst | Apr 1, 2015
Scientist to Watch Yvonne Saenger explains recent advances in using biomarkers to identify cancer patients who might benefit most from immunotherapy.
To Each His Own
To Each His Own
Mary Beth Aberlin | Apr 1, 2015
Cancer treatment becomes more and more personal.
The CAR T-Cell Race
The CAR T-Cell Race
Vicki Brower | Apr 1, 2015
Tumor-targeting T-cell therapies are generating remarkable remissions in hard-to-beat cancers—and attracting millions of dollars of investment along the way.
Yvonne Saenger: Immunotherapy Pioneer
Yvonne Saenger: Immunotherapy Pioneer
Jef Akst | Apr 1, 2015
Assistant Professor, Department of Medicine, Columbia University. Age: 41
T Cells of the Skin
T Cells of the Skin
Ruth Williams | Mar 18, 2015
A census of adaptive immune system components in human skin reveals a variety of resident and traveling memory T cells.